ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, cilt.312, ss.55-65, 1991 (SCI-Expanded)
In this study, the combination of a thromboxane synthetase inhibitor (UK 38 485) and a thromboxane receptor antagonist (ICI 185 282) was tested for an interaction of potential therapeutic importance and the effect of acetylsalicylic acid pretreatment on this combination was evaluated in digoxin-induced arrhythmias in guinea-pigs. Drug treatments at the dose combinations used (ICI 185 282: 0.2 mg/kg + 0.2 mg/kg/hr + UK 38 485 0.1 mg/kg/hr and ICI 185 282: 2 mg/kg + 2 mg/kg/hr + UK 38 485 1 mg/kg/hr) markedly reduced the incidence of ventricular fibrillation, mortality rate and arrhythmia score. Pretreatment with acetylsalicylic acid plus drug combination resulted in a dose-dependent increase in mortality rate and arrhythmia score.